The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection.

Autor: Ward D; Dept of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark djwa@dcm.aau.dk.; Dept of Clinical Medicine, Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Aalborg University, Copenhagen, Denmark., Gørtz S; Dept of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark., Thomson Ernst M; Dept of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark., Andersen NN; Dept of Medical Gastroenterology and Hepatology, Rigshospitalet, Copenhagen, Denmark., Kjær SK; Unit of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark., Hallas J; Research Unit of Clinical Pharmacology, University of Southern Denmark, Odense, Denmark., Christensen S; Dept of Intensive Care, Aarhus University Hospital, Aarhus, Denmark., Fynbo Christiansen C; Dept of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark., Bastrup Israelsen S; Dept of Infectious Diseases, Center of Research and Disruption of Infectious Diseases (CREDID), Copenhagen University Hospital, Amager and Hvidovre Hospital, Hvidovre, Denmark., Benfield T; Dept of Infectious Diseases, Center of Research and Disruption of Infectious Diseases (CREDID), Copenhagen University Hospital, Amager and Hvidovre Hospital, Hvidovre, Denmark., Pottegård A; Dept of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark., Jess T; Dept of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.; Dept of Clinical Medicine, Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Aalborg University, Copenhagen, Denmark.

Publikováno v: The European respiratory journal [Eur Respir J] 2022 Apr 07; Vol. 59 (4). Date of Electronic Publication: 2022 Apr 07 (Print Publication: 2022).